Magenta Therapeutics Presents Positive MGTA-117 Clinical
– MGTA-117 preliminary clinical results from 15 patients across three dose-escalation cohorts of the ongoing Phase 1/2 clinical trial shows single-agent...
United Kingdom United States Jill Bertotti Jason Gardner Exchange Commission American Society Of Hematology
Source: globenewswire.com